Suchergebnisse - "MOUSSA ADEL"

PubPharm (232)

1

DOSAGE REGIMENS FOR TREATMENT OF DENGUE INFECTION

enthalten in: Europäisches Patentamt | 2024

von MOUSSA ADEL | CHAUDHURI NARAYAN | GOOD STEVEN | +7

2

2'-CHLORO-2'-FLUORO-N2-AMINO-N6-METHYLAMINO PURINE NUCLEOTIDES FOR FLAVIVIRUS TREATMENT

enthalten in: Europäisches Patentamt | 2024

von SOMMADOSSI JEAN-PIERRE | MOUSSA ADEL

3

유리한 항-HCV 조합 요법

enthalten in: Europäisches Patentamt | 2024

von SOMMADOSSI JEAN PIERRE | MOUSSA ADEL | PIETROPAOLO KEITH M | +1

4

The activation chain of the broad-spectrum antiviral bemnifosbuvir at atomic resolution

enthalten in: bioRxiv.org | 2024

von Chazot, A. | Zimberger, C. | Feracci, M. | +6

5

An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complex

enthalten in: Nucleic acids research | 2024

von Shannon, A. | Chazot, A. | Feracci, M. | +9

6

Advantageous anti-HCV combination therapy

enthalten in: Europäisches Patentamt | 2024

von SOMMADOSSI JEAN-PIERRE | MOUSSA ADEL | PETROPAUL KAREN M | +1

7

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

enthalten in: Europäisches Patentamt | 2024

von MOUSSA ADEL | SOMMADOSSI JEAN-PIERRE

8

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

enthalten in: Europäisches Patentamt | 2024

von MOUSSA ADEL | SOMMADOSSI JEAN-PIERRE

9

Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase

enthalten in: Expert opinion on investigational drugs | 2024

von Zhou, X. | Good, S. | Pietropaolo, K. | +4

10

ADVANTAGEOUS ANTI-HCV COMBINATION THERAPY

enthalten in: Europäisches Patentamt | 2024

von SOMMADOSSI JEAN-PIERRE | MOUSSA ADEL | PIETROPAOLO KEITH | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]